Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haneda

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Nature|April 7, 1983
Three mutant insulins in manS Shoelson, M Haneda, P Blix, et al.
The Journal of International Medical Research|December 24, 2005
The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) StudyH Makino, M Haneda, T Babazono, et al.
Nephron|June 12, 1999
Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patientsY Tomino, Y Makita, T Shike, et al.
Journal of the American Society of Nephrology : JASN|December 10, 1999
Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullinM Kohno, K Yasunari, M Minami, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
On kynureninase activityY Shibata, F Takeuchi, R Tsubouchi, et al.
Diabetes Research and Clinical Practice|September 13, 2015
Prevalence of resistant hypertension and associated factors in Japanese subjects with type 2 diabetesH Yokoyama, S Araki, S Watanabe, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2000
Evaluation of a new care system provided to diabetic patients in the outpatient clinicH Hidaka, M Terada, H Maegawa, et al.
Diabetes Care|June 2, 2000
Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patientsH Yasuda, A Hirai, M Joko, et al.
Diabetologia|September 16, 2000
Usefulness of waveform analysis of popliteal artery in type II diabetic patients using gated magnetic resonance 2D-cine-PC imaging and 31P spectroscopyE Suzuki, A Kashiwagi, Y Nishio, et al.
Kidney International|September 29, 2001
Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathyS Maeda, M Haneda, B Guo, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Nature|April 7, 1983
Three mutant insulins in manS Shoelson, M Haneda, P Blix, et al.
The Journal of International Medical Research|December 24, 2005
The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) StudyH Makino, M Haneda, T Babazono, et al.
Nephron|June 12, 1999
Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patientsY Tomino, Y Makita, T Shike, et al.
Journal of the American Society of Nephrology : JASN|December 10, 1999
Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullinM Kohno, K Yasunari, M Minami, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
On kynureninase activityY Shibata, F Takeuchi, R Tsubouchi, et al.
Diabetes Research and Clinical Practice|September 13, 2015
Prevalence of resistant hypertension and associated factors in Japanese subjects with type 2 diabetesH Yokoyama, S Araki, S Watanabe, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2000
Evaluation of a new care system provided to diabetic patients in the outpatient clinicH Hidaka, M Terada, H Maegawa, et al.
Diabetes Care|June 2, 2000
Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patientsH Yasuda, A Hirai, M Joko, et al.
Diabetologia|September 16, 2000
Usefulness of waveform analysis of popliteal artery in type II diabetic patients using gated magnetic resonance 2D-cine-PC imaging and 31P spectroscopyE Suzuki, A Kashiwagi, Y Nishio, et al.
Kidney International|September 29, 2001
Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathyS Maeda, M Haneda, B Guo, et al.
Pageof 15